News

Results of ongoing Phase 1/2 trial for BL-7010 expected in next few weeks.

A study by researchers at IRB Barcelona reveals the existence of information highways that connect and correlate distant sites within a single protein.

Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial in adult and paediatric patients with impetigo, is available from Ferrer for licensing and commercialization.

Confirmation of quality of TxCell’s manufacturing platform by ANSM enables regulatory submissions for Ovasave® phase IIb clinical study.

This review focuses on the culturing of cell lines representative of solid cancers in advanced cell culture conditions.

Ultra-modern clean room manufacturing cell for elastomer and plastic components is specifically designed for meeting the demands of the medical and pharmaceutical industries.

Partnership is focused on the potential development of several programs for the treatment of inflammatory and orphan diseases.

Professors Jairton Dupont, David Amabilino and Lam Hon will work at the laboratory which is due for completion early 2015.

University of Pennsylvania researchers have shown that dendrimer-based vesicles self-assemble with concentric layers of membranes, much like an onion.

Research from the University of Cambridge suggests improvements in patients with cardiovascular disease taking the daily supplement.